The first expansion opportunity was the potential to receive European marketing approval for nirogacestat (OGSIVEO) for the treatment of adults with desmoid tumors. It was able to have its ...

Notably, SpringWorks' portfolio of rare tumor treatments, including a first-in-class, systemic standard-of-care therapy for adults with desmoid tumors and the only approved treatment for adults ...

The company, which is focused on severe rare diseases and cancer, has already developed and commercialized the FDA-approved medicine OGSIVEO® for desmoid tumors and GOMEKLI™ for ...

Work began Friday and is scheduled to run through June 13. Repairs are underway at Prouts Neck in Scarborough to remedy erosion and other damage from the winter storms in January 2024. Black Point ...

By Carly Thomas Associate Editor Teddi Mellencamp is sharing a positive health update after learning she had multiple tumors and then undergoing emergency brain surgery earlier this year.

The Narwal family from Sector-7, Karnal, Haryana, is shattered after losing their only son, Lieutenant Vinay Narwal, Initial reports suggest that the officer was shot in the chest, neck ...

During a live event, Richard F. Riedel, MD, discussed key efficacy and safety outcomes from the phase 3 DeFi trial in patients with progressing desmoid tumors. This was a randomized phase 3 study for ...

The role of pyroptosis in the tumor microenvironment of head and neck squamous cell carcinoma (HNSCC) [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2025; ...

“In the near future, PD-1 monotherapy is likely to be standard of care in the neoadjuvant preoperative setting for head and neck cancer,” Robert L. Ferris, MD, PhD, study co-author and ...

During a live event, Richard F. Riedel, MD, discussed Desmoid Tumor Working Group and NCCN guidelines for treating patients with desmoid tumors. Richard F. Riedel, MD: The Desmoid Tumor Working Group ...